Holen Sie sich die Stockscreener-App
4.745
4.72%
-0.235
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.16%
13.21
|
11.18 | 8.13 | 8.757 | 8.571 |
| Interest Income/Expense |
31.78%
0.161
|
0.236 | 0.306 | 0.487 | 0.567 |
| Operating Income/Loss |
18.16%
-13.21
|
-11.18 | -8.13 | -8.757 | -8.571 |
| Nonoperating Income/Loss |
69.63%
1.938
|
6.381 | 15.51 | -1.889 | -13.67 |
| Income/Loss From Continuing Operations Before Tax |
134.97%
-11.27
|
-4.796 | 7.379 | -10.65 | -22.24 |
| Income/Loss From Continuing Operations After Tax |
134.97%
-11.27
|
-4.796 | 7.379 | -10.65 | -22.24 |
|
Net Income/Loss
|
134.97%
-11.27
|
-4.796 | 7.379 | -10.65 | -22.24 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6.61%
54.89
|
51.49 | 50.48 | 32.01 | 29.88 |
| Diluted Average Shares |
6.61%
54.89
|
51.49 | 54.77 | 32.01 | 29.88 |
| Basic Earnings Per Share |
133.33%
-0.21
|
-0.09 | 0.15 | -0.33 | -0.74 |
| Diluted Earnings Per Share |
133.33%
-0.21
|
-0.09 | 0.13 | -0.33 | -0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):